pazopanib_NCRCC,Ph2 STUDY

Clinical trial NCT01538238 · COMPLETED

Trial details

NCT number: NCT01538238
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma

Start date: 2012-05-02
Primary completion: 2015-02-28
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.